373 related articles for article (PubMed ID: 16123432)
1. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
[TBL] [Abstract][Full Text] [Related]
2. Posterior vitreous detachment induced by microplasmin.
Gandorfer A; Rohleder M; Sethi C; Eckle D; Welge-Lüssen U; Kampik A; Luthert P; Charteris D
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):641-7. PubMed ID: 14744909
[TBL] [Abstract][Full Text] [Related]
3. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.
de Smet MD; Gandorfer A; Stalmans P; Veckeneer M; Feron E; Pakola S; Kampik A
Ophthalmology; 2009 Jul; 116(7):1349-55, 1355.e1-2. PubMed ID: 19447497
[TBL] [Abstract][Full Text] [Related]
4. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy.
Chen W; Mo W; Sun K; Huang X; Zhang YL; Song HY
Curr Eye Res; 2009 Dec; 34(12):1057-64. PubMed ID: 19958125
[TBL] [Abstract][Full Text] [Related]
5. Microplasmin: ex vivo characterization of its activity in porcine vitreous.
de Smet MD; Valmaggia C; Zarranz-Ventura J; Willekens B
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):814-9. PubMed ID: 18806295
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a stabilized form of microplasmin for the induction of posterior vitreous detachment.
Gad Elkareem AM; Willekens B; Vanhove M; Noppen B; Stassen JM; de Smet MD
Curr Eye Res; 2010 Oct; 35(10):909-15. PubMed ID: 20858112
[TBL] [Abstract][Full Text] [Related]
7. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.
Quiram PA; Leverenz VR; Baker RM; Dang L; Giblin FJ; Trese MT
Retina; 2007 Oct; 27(8):1090-6. PubMed ID: 18040251
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator.
Chen W; Huang X; Ma XW; Mo W; Wang WJ; Song HY
Eye (Lond); 2008 Feb; 22(2):300-7. PubMed ID: 17704761
[TBL] [Abstract][Full Text] [Related]
9. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Assessment of Pharmacologic Vitreolysis in Rabbits With the Digital Fluoroscopy System.
Bae JH; Park HS; Kim JM; Lee BR; Lee SC; Tandogan T; Auffarth GU; Koss MJ; Choi CY
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4817-22. PubMed ID: 26218910
[TBL] [Abstract][Full Text] [Related]
11. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.
Wang ZL; Zhang X; Xu X; Sun XD; Wang F
Retina; 2005 Jan; 25(1):38-43. PubMed ID: 15655439
[TBL] [Abstract][Full Text] [Related]
12. Experiment of vitreous liquefaction induced by C3F8.
Wang J; Li Q
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):281-287. PubMed ID: 28625955
[TBL] [Abstract][Full Text] [Related]
13. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of plasmin on the vitreolysis in rabbit eyes.
Kim NJ; Yu HG; Yu YS; Chung H
Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.
Hermel M; Mahgoub M; Youssef T; Azrak MI; Raza H; Alldredge C; Trese M; Williams GA; Hartzer M
Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):996-1002. PubMed ID: 16365737
[TBL] [Abstract][Full Text] [Related]
16. Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis.
Takano A; Hirata A; Ogasawara K; Sagara N; Inomata Y; Kawaji T; Tanihara H
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2075-9. PubMed ID: 16639018
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis.
Wang F; Wang Z; Sun X; Wang F; Xu X; Zhang X
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3286-90. PubMed ID: 15326153
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
Hikichi T; Kado M; Yoshida A
Retina; 2000; 20(2):195-8. PubMed ID: 10783954
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels.
Giblin FJ; Quiram PA; Leverenz VR; Baker RM; Dang L; Trese MT
Exp Eye Res; 2009 Feb; 88(2):286-92. PubMed ID: 18835558
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats.
Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J
Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
